Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study. J of Skin [Internet]. 2023 Jul. 17 [cited 2025 May 19];7(4):s224. Available from: https://skin.dermsquared.com/skin/article/view/2186